Earl Collier

Earl Collier

Director/Board Member presso CAPRICOR THERAPEUTICS, INC.

Patrimonio netto: 386 052 $ in data 31/03/2024

76 anni
Health Technology
Commercial Services
Health Services

Profilo

Earl M.
Collier
is currently the Chairman at Newton-Wellesley Hospital Corp.
He is also an Independent Director at Capricor Therapeutics, Inc., a Director at Codex Foundation, a Trustee at Boston Athenæum, an Advisor at InCube Venture Partners LLC, a Member at The Grolier Club of New York, and a Member at Book Club of California.
Previously, Mr. Collier held several positions including Chief Executive Officer & Director at deCODE genetics, Inc., Executive Chairman & Chief Executive Officer at Arsenal Medical, Inc., Chief Executive Officer & Director at Lyra Therapeutics, Inc., and Director at Capricor, Inc., Tesaro, Inc., TransMedics, Inc., Mass General Brigham, Inc., Encorium Group, Inc., and Gensight Biologics SA. He was also the President at VITAS Healthcare Corp.
and Partner at Hogan & Hartson LLP.
Additionally, he served as President at Genzyme Biosurgery Corp., Deputy Administrator at Centers for Medicare & Medicaid Services (US), and Deputy Administrator at US Department of Health & Human Services (DC).
Mr. Collier was also the Executive VP-Cardiovascular, Oncology & Genetics at Genzyme Corp.Mr. Collier completed his undergraduate studies at Yale University and obtained a graduate degree from the University of Virginia School of Law.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
23/04/2024 56 856 ( 0.18% ) 386 052 $ 31/03/2024

Posizioni attive di Earl Collier

SocietàPosizioneInizio
CAPRICOR THERAPEUTICS, INC. Director/Board Member 20/11/2013
Codex Foundation Director/Board Member -
Book Club of California Corporate Officer/Principal -
The Grolier Club of New York Corporate Officer/Principal -
Director/Board Member -
Consultant / Advisor -
Chairman -
Tutte le posizioni attive di Earl Collier

Precedenti posizioni note di Earl Collier

SocietàPosizioneFine
GENSIGHT BIOLOGICS S.A. Director/Board Member 19/04/2017
Chief Executive Officer 01/01/2015
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Earl Collier

Formazione di Earl Collier

Yale University Undergraduate Degree
University of Virginia School of Law Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Earl Collier

Relazioni

100 +

Relazioni di 1° grado

24

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
LYRA THERAPEUTICS, INC.

Health Technology

GENSIGHT BIOLOGICS S.A.

Health Technology

CAPRICOR THERAPEUTICS, INC.

Health Technology

Aziende private19

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Government

Health Services

Health Services

US Department of Health & Human Services (DC)

Government

Commercial Services

Finance

The Grolier Club of New York

Book Club of California

Codex Foundation

Vedi le connessioni aziendali